4//SEC Filing
Edge Therapeutics, Inc. 4
Accession 0001127602-16-044513
$PDSBCIK 0001472091operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:21 PM ET
Size
5.2 KB
Accession
0001127602-16-044513
Insider Transaction Report
Form 4
Faleck Herbert J
Chief Medical Officer
Transactions
- Award
Stock Option (right To Purchase)
2016-03-01+25,000→ 25,000 totalExercise: $7.24Exp: 2026-03-01→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 25,000 shares of Common Stock, will become exercisable on February 16, 2017, with a 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001472091
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:21 PM ET
- Size
- 5.2 KB